Table 1

In vitro effects of exisulind and docetaxel alone and in combination on cell cycle distribution and % of apoptotic cells in A549 NSCLC cells

Treatment	% G₁^a	% S	% G₂-M	% Apoptosis
Control 24 h	46	38	16	0
Exi 200 μm	60	22	18	0.1
Exi 300 μm	65	14	21	0
Doce 0.2 nm	42	39	19	0
Doce 0.5 nm	38	41	21	0.05
Doce 1 nm	46	40	14	0.58
Doce 3 nm	32	57	11	11
Control 12 h	51	33	16	0
Docetaxel 6 nm	30	50	20	34
Docetaxel 10 nm	10	51	39	64
Control 24 h	46	38	16	0
Exi 200 μm + Doce 0.2 nm	59	21	20	0.47
Exi 200 μm + Doce 0.5 nm	54	28	19	9.4
Exi 200 μm + Doce 1 nm	46	8	46	5
Exi 300 μm + Doce 0.2 nm	58	17	25	5
Exi 300 μm + Doce 0.5 nm	43	24	33	39
Exi 300 μm + Doce 1 nm	51	36	13	62